Form 4 for AURA Aura Biosciences, Inc.

Accepted 2021-11-02 00:00:00 ET · period of report 2021-11-02 · accession 0000899243-21-042361 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2021-11-02	2021-11-02	AURA	Johnson David Michael	Dir	C - Cnv Deriv	$0.00	+139.7K	139.7K	New	$0
DI	2021-11-02	2021-11-02	AURA	Johnson David Michael	Dir	C - Cnv Deriv	—	-139.7K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-11-02	C	A	139,672	$0.00	139,672	I By Velocity Capital Management	—	—	(F1) The Series E Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021. (F2) Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
2	Derivative	Series E Convertible Preferred Stock	2021-11-02	C	D	139,672	—	0	I By Velocity Capital Management LLC	— · — to —	139,672 Common Stock	(F1) The Series E Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021. (F2) Velosity Capital Management LLC is an entity that the reporting person is the sole member of.